148 related articles for article (PubMed ID: 12825950)
1. N-(3-acyloxy-2-benzylpropyl)-N'-[4-(methylsulfonylamino)benzyl]thiourea analogues: novel potent and high affinity antagonists and partial antagonists of the vanilloid receptor.
Lee J; Lee J; Kang M; Shin M; Kim JM; Kang SU; Lim JO; Choi HK; Suh YG; Park HG; Oh U; Kim HD; Park YH; Ha HJ; Kim YH; Toth A; Wang Y; Tran R; Pearce LV; Lundberg DJ; Blumberg PM
J Med Chem; 2003 Jul; 46(14):3116-26. PubMed ID: 12825950
[TBL] [Abstract][Full Text] [Related]
2. Analysis of structure-activity relationships for the 'B-region' of N-(3-acyloxy-2-benzylpropyl)-N(')-[4-(methylsulfonylamino)benzyl]thiourea analogues as vanilloid receptor antagonists: discovery of an N-hydroxythiourea analogue with potent analgesic activity.
Lee J; Kang SU; Choi HK; Lee J; Lim JO; Kil MJ; Jin MK; Kim KP; Sung JH; Chung SJ; Ha HJ; Kim YH; Pearce LV; Tran R; Lundberg DJ; Wang Y; Toth A; Blumberg PM
Bioorg Med Chem Lett; 2004 May; 14(9):2291-7. PubMed ID: 15081027
[TBL] [Abstract][Full Text] [Related]
3. High-affinity partial agonists of the vanilloid receptor.
Wang Y; Toth A; Tran R; Szabo T; Welter JD; Blumberg PM; Lee J; Kang SU; Lim JO; Lee J
Mol Pharmacol; 2003 Aug; 64(2):325-33. PubMed ID: 12869637
[TBL] [Abstract][Full Text] [Related]
4. Analysis of structure-activity relationships with the N-(3-acyloxy-2-benzylpropyl)-N'-[4-(methylsulfonylamino)benzyl]thiourea template for vanilloid receptor 1 antagonism.
Lee J; Kim SY; Lee J; Kang M; Kil MJ; Choi HK; Jin MK; Wang Y; Toth A; Pearce LV; Lundberg DJ; Tran R; Blumberg PM
Bioorg Med Chem; 2004 Jul; 12(13):3411-20. PubMed ID: 15186827
[TBL] [Abstract][Full Text] [Related]
5. Analysis of structure-activity relationships for the 'A-region' of N-(4-t-butylbenzyl)-N'-[4-(methylsulfonylamino)benzyl]thiourea analogues as TRPV1 antagonists.
Lee J; Kang SU; Kil MJ; Shin M; Lim JO; Choi HK; Jin MK; Kim SY; Kim SE; Lee YS; Min KH; Kim YH; Ha HJ; Tran R; Welter JD; Wang Y; Szabo T; Pearce LV; Lundberg DJ; Toth A; Pavlyukovets VA; Morgan MA; Blumberg PM
Bioorg Med Chem Lett; 2005 Sep; 15(18):4136-42. PubMed ID: 16005215
[TBL] [Abstract][Full Text] [Related]
6. High affinity antagonists of the vanilloid receptor.
Wang Y; Szabo T; Welter JD; Toth A; Tran R; Lee J; Kang SU; Suh YG; Blumberg PM; Lee J
Mol Pharmacol; 2002 Oct; 62(4):947-56. PubMed ID: 12237342
[TBL] [Abstract][Full Text] [Related]
7. Analysis of structure-activity relationships for the 'B-region' of N-(4-t-butylbenzyl)-N'-[4-(methylsulfonylamino)benzyl]-thiourea analogues as TRPV1 antagonists.
Lee J; Jin MK; Kang SU; Kim SY; Lee J; Shin M; Hwang J; Cho S; Choi YS; Choi HK; Kim SE; Suh YG; Lee YS; Kim YH; Ha HJ; Toth A; Pearce LV; Tran R; Szabo T; Welter JD; Lundberg DJ; Wang Y; Lazar J; Pavlyukovets VA; Morgan MA; Blumberg PM
Bioorg Med Chem Lett; 2005 Sep; 15(18):4143-50. PubMed ID: 15993063
[TBL] [Abstract][Full Text] [Related]
8. Alpha-substituted N-(4-tert-butylbenzyl)-N'-[4-(methylsulfonylamino)benzyl]thiourea analogues as potent and stereospecific TRPV1 antagonists.
Chung JU; Kim SY; Lim JO; Choi HK; Kang SU; Yoon HS; Ryu H; Kang DW; Lee J; Kang B; Choi S; Toth A; Pearce LV; Pavlyukovets VA; Lundberg DJ; Blumberg PM
Bioorg Med Chem; 2007 Sep; 15(18):6043-53. PubMed ID: 17629487
[TBL] [Abstract][Full Text] [Related]
9. Structure-activity relationships of simplified resiniferatoxin analogues with potent VR1 agonism elucidates an active conformation of RTX for VR1 binding.
Lee J; Kim SY; Park S; Lim JO; Kim JM; Kang M; Lee J; Kang SU; Choi HK; Jin MK; Welter JD; Szabo T; Tran R; Pearce LV; Toth A; Blumberg PM
Bioorg Med Chem; 2004 Mar; 12(5):1055-69. PubMed ID: 14980619
[TBL] [Abstract][Full Text] [Related]
10. N-[4-(methylsulfonylamino)benzyl]thiourea analogues as vanilloid receptor antagonists: analysis of structure-activity relationships for the "C-Region".
Lee J; Kang SU; Lim JO; Choi HK; Jin MK; Toth A; Pearce LV; Tran R; Wang Y; Szabo T; Blumberg PM
Bioorg Med Chem; 2004 Jan; 12(2):371-85. PubMed ID: 14723956
[TBL] [Abstract][Full Text] [Related]
11. N-4-methansulfonamidobenzyl-N'-2-substituted-4-tert-butyl-benzyl thioureas as potent vanilloid receptor antagonistic ligands.
Park HG; Choi JY; Choi SH; Park MK; Lee J; Suh YG; Cho H; Oh U; Kim HD; Joo YH; Kim SY; Park YH; Jeong YS; Choi JK; Kim JK; Jew SS
Bioorg Med Chem Lett; 2004 Apr; 14(7):1693-6. PubMed ID: 15026052
[TBL] [Abstract][Full Text] [Related]
12. N-(3-Acyloxy-2-benzylpropyl)-N'-(4-hydroxy-3-methoxybenzyl) thiourea derivatives as potent vanilloid receptor agonists and analgesics.
Lee J; Lee J; Kim J; Kim SY; Chun MW; Cho H; Hwang SW; Oh U; Park YH; Marquez VE; Beheshti M; Szabo T; Blumberg PM
Bioorg Med Chem; 2001 Jan; 9(1):19-32. PubMed ID: 11197340
[TBL] [Abstract][Full Text] [Related]
13. N-4-Substituted-benzyl-N'-tert-butylbenzyl thioureas as vanilloid receptor ligands: investigation on the role of methanesulfonamido group in antagonistic activity.
Park HG; Choi JY; Choi SH; Park MK; Lee J; Suh YG; Cho H; Oh U; Lee J; Kang SU; Lee J; Kim HD; Park YH; Su Jeong Y; Kyu Choi J; Jew SS
Bioorg Med Chem Lett; 2004 Feb; 14(3):787-91. PubMed ID: 14741290
[TBL] [Abstract][Full Text] [Related]
14. N-(4-tertiarybutylphenyl)-4-(3-chloropyridin-2-yl)tetrahydropyrazine -1(2H)-carbox-amide (BCTC), a novel, orally effective vanilloid receptor 1 antagonist with analgesic properties: I. in vitro characterization and pharmacokinetic properties.
Valenzano KJ; Grant ER; Wu G; Hachicha M; Schmid L; Tafesse L; Sun Q; Rotshteyn Y; Francis J; Limberis J; Malik S; Whittemore ER; Hodges D
J Pharmacol Exp Ther; 2003 Jul; 306(1):377-86. PubMed ID: 12721338
[TBL] [Abstract][Full Text] [Related]
15. 3-D-QSAR analysis of N-(3-acyloxy-2-benzylpropyl)-N'-dihydroxytetrahydrobenzazepine and tetrahydroisoquinoline and N-(3-acyloxy-2-benzylpropyl)-N'-(4-hydroxy-3-methoxybenzyl) thioureas analogues as potent vanilloid receptor ligands.
Kim KH
Bioorg Med Chem; 2002 May; 10(5):1367-72. PubMed ID: 11886800
[TBL] [Abstract][Full Text] [Related]
16. Halogenation of a capsaicin analogue leads to novel vanilloid TRPV1 receptor antagonists.
Appendino G; Harrison S; De Petrocellis L; Daddario N; Bianchi F; Schiano Moriello A; Trevisani M; Benvenuti F; Geppetti P; Di Marzo V
Br J Pharmacol; 2003 Aug; 139(8):1417-24. PubMed ID: 12922928
[TBL] [Abstract][Full Text] [Related]
17. N-(3-acyloxy-2-benzylpropyl)-N'-dihydroxytetrahydrobenzazepine and tetrahydroisoquinoline thiourea analogues as vanilloid receptor ligands.
Lee J; Lee J; Szabo T; Gonzalez AF; Welter JD; Blumberg PM
Bioorg Med Chem; 2001 Jul; 9(7):1713-20. PubMed ID: 11425572
[TBL] [Abstract][Full Text] [Related]
18. Design of a high-affinity competitive antagonist of the vanilloid receptor selective for the calcium entry-linked receptor population.
Tóth A; Blumberg PM; Chen Z; Kozikowski AP
Mol Pharmacol; 2004 Feb; 65(2):282-91. PubMed ID: 14742669
[TBL] [Abstract][Full Text] [Related]
19. Novel vanilloid receptor-1 antagonists: 1. Conformationally restricted analogues of trans-cinnamides.
Norman MH; Zhu J; Fotsch C; Bo Y; Chen N; Chakrabarti P; Doherty EM; Gavva NR; Nishimura N; Nixey T; Ognyanov VI; Rzasa RM; Stec M; Surapaneni S; Tamir R; Viswanadhan VN; Treanor JJ
J Med Chem; 2007 Jul; 50(15):3497-514. PubMed ID: 17585749
[TBL] [Abstract][Full Text] [Related]
20. Structure-activity relationships and molecular modeling of the N-(3-pivaloyloxy-2-benzylpropyl)-N'-[4-(methylsulfonylamino)benzyl] thiourea template for TRPV1 antagonism.
Bhondwe RS; Kang DW; Kim MS; Kim HS; Park SG; Son K; Choi S; Kuhs KA; Pavlyukovets VA; Pearce LV; Blumberg PM; Lee J
Bioorg Med Chem Lett; 2012 Jun; 22(11):3656-60. PubMed ID: 22546668
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
